Details for New Drug Application (NDA): 210856
✉ Email this page to a colleague
The generic ingredient in CLADRIBINE is cladribine. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cladribine profile page.
Summary for 210856
Tradename: | CLADRIBINE |
Applicant: | Hisun Pharm Hangzhou |
Ingredient: | cladribine |
Patents: | 0 |
Suppliers and Packaging for NDA: 210856
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLADRIBINE | cladribine | INJECTABLE;INJECTION | 210856 | ANDA | Hisun Pharmaceuticals USA, Inc. | 42658-010 | 42658-010-01 | 1 mL in 1 VIAL, SINGLE-DOSE (42658-010-01) |
CLADRIBINE | cladribine | INJECTABLE;INJECTION | 210856 | ANDA | Hisun Pharmaceuticals USA, Inc. | 42658-010 | 42658-010-91 | 1 mL in 1 VIAL, SINGLE-DOSE (42658-010-91) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
Approval Date: | Nov 25, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription